نتایج جستجو برای: leishmania soluble antigen

تعداد نتایج: 296187  

2014
Rym Chamakh-Ayari Rachel Bras-Gonçalves Narges Bahi-Jaber Elodie Petitdidier Wafa Markikou-Ouni Karim Aoun Javier Moreno Eugenia Carrillo Poonam Salotra Himanshu Kaushal Narender Singh Negi Jorge Arevalo Francesca Falconi-Agapito Angela Privat Maria Cruz Julie Pagniez Gérard-Marie Papierok Faten Bel Haj Rhouma Pilar Torres Jean-Loup Lemesre Mehdi Chenik Amel Meddeb-Garnaoui

PSA (Promastigote Surface Antigen) belongs to a family of membrane-bound and secreted proteins present in several Leishmania (L.) species. PSA is recognized by human Th1 cells and provides a high degree of protection in vaccinated mice. We evaluated humoral and cellular immune responses induced by a L. amazonensis PSA protein (LaPSA-38S) produced in a L. tarentolae expression system. This was d...

2017
Jade Katinas Rachel Epplin Christopher Hamaker Marjorie A. Jones

Introduction Leishmaniasis is an endemic disease caused by the protozoan parasite Leishmania. Current treatments for the parasite are limited by cost, availability and drug resistance as the occurrence of leishmaniasis continues to be more prevalent. Sulfonamides are a class of compounds with medicinal properties which have been used to treat bacterial and parasitic disease via various pathways...

Journal: :Archivum immunologiae et therapiae experimentalis 2000
K Kemp

Leishmania specific Th1/Th2 cells have been identified in humans as well as in mice. There is a correlation between the clinical outcome of the infection and the cytokine response profile. Generally, the production of Th2 cytokines leads to severe infection, whereas the production of Th1 cytokines leads to subclinical or mild infections. In mice, an infection leads to a polarisation of either T...

2012
Om Prakash Singh Carmel B. Stober Abhishek Kr. Singh Jenefer M. Blackwell Shyam Sundar

BACKGROUND There are no effective vaccines for visceral leishmaniasis (VL), a neglected parasitic disease second only to malaria in global mortality. We previously identified 14 protective candidates in a screen of 100 Leishmania antigens as DNA vaccines in mice. Here we employ whole blood assays to evaluate human cytokine responses to 11 of these antigens, in comparison to known defined and cr...

2012
Daniel R. Abánades Leonardo V. Arruda Elaine S. Arruda José Roberto A. S. Pinto Mario S. Palma Dorlene Aquino Arlene J. Caldas Manuel Soto Aldina Barral Manoel Barral-Netto

BACKGROUND Protection and recovery from visceral leishmaniasis (VL) have been associated with cell-mediated immune (CMI) responses, whereas no protective role has been attributed to humoral responses against specific parasitic antigens. In this report, we compared carefully selected groups of individuals with distinct responses to Leishmania chagasi to explore antigen-recognizing IgG present in...

Journal: :The Journal of Experimental Medicine 2000
Peter E. Kima Stephanie L. Constant Lynn Hannum Maria Colmenares Karen S. Lee Ann M. Haberman Mark J. Shlomchik Diane McMahon-Pratt

We show here that maintenance of Leishmania infections with Leishmania mexicana complex parasites (Leishmania amazonensis and Leishmania pifanoi) is impaired in the absence of circulating antibody. In these studies, we used mice genetically altered to contain no circulating antibody, with and without functional B cells. This experimental design allowed us to rule out a critical role for B cell ...

Journal: :Infection and immunity 1992
M Kemp M B Hansen T G Theander

Crude antigen preparations of Leishmania promastigote sonicates were found to induce in vitro proliferation and gamma interferon production in peripheral blood mononuclear cells (PBMC) from individuals without known exposure to the parasite. The proliferating cells were mainly CD2-positive T cells. The proliferative response was maximal after more than 6 days of incubation with the antigens in ...

Journal: :novelty in biomedicine 0
mehdi shokri immunology department and virology department, pasteur institute of iran, tehran, iran soheila ajdary immunology department, pasteur institute of iran, tehran, iran mina ebrahimi-rad biochemistry department, pasteur institute of iran, tehran, iran arash memarnejadian hepatitis and aids department, pasteur institute of iran, tehran, iran mohamad-hossein alimohamadian immunology department, pasteur institute of iran, tehran, iran fatemeh motevali hepatitis and aids department, pasteur institute of iran, tehran, iran

background: leishmania major lmsti1 is a conserved protein among different species of leishmania, and expressed in both amastigote and promastigote forms of l. major life cycle. it has previously been expressed in bacterial systems. m aterials and methods: to express lmsti1 in the methylotrophic yeast         pichia pastoris ( p. pastoris ), the shuttle vector ppicza containing gene lmsti1 was ...

Journal: :Turkiye parazitolojii dergisi 2013
Afshineh Latifynia Ali Khamisipour Mohammad Javad Gharagozlou Said Bokaie Mohammad Vodjgani Zahra Gheflati Marzieh Mosavi Nematollah Khansari

OBJECTIVE The aim of this study was to carry out experiments further to our previous new formulation to modify the Leishmania major antigen that had satisfactory results previously. METHODS In this study we made a preliminary, new vaccine with the same methodology and selected two injection doses (100&200 μg/o.1 mL), three injection Groups: Leishmania plus BCG (LB), Leishmania plus new adjuva...

Journal: :The Journal of infectious diseases 2004
Kelly Wilber Quispe Tintaya Xu Ying Jean-Pierre Dedet Suman Rijal Xavier De Bolle Jean-Claude Dujardin

BACKGROUND Efficient monitoring of endemic and resurgent visceral leishmaniasis (VL) requires discriminatory molecular tools that allow direct characterization of etiological agents (i.e., the Leishmania donovani complex) in host tissues. This characterization is possible through restriction fragment-length polymorphism (RFLP) analysis of polymerase chain reaction (PCR)-amplified sequences (PCR...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید